Men using phosphodiesterase type 5 (PDE-5) inhibitors for erectile dysfunction (ED) had a modestly lower risk of glaucoma, according to a study reported here. During 3 years of follow-up, men taking ...

Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It's a ...

The FDA issued a priority voucher promising a quick review of zenocutuzumab (Bizengri) for previously treated advanced, ...

A new systematic review in The BMJ reported that current evidence did not support causal associations between aluminium ...

The family of an Oregon teen who died after a doctor stitched up a cut but allegedly failed to remove the pine needles and ...

The relative vaccine efficacy of mRNA-1010 appeared to be generally consistent across the three influenza strains and across ...

More than two dozen passengers potentially exposed to hantavirus aboard a cruise ship disembarked almost 2 weeks ago, several ...

The investigational drug daraxonrasib, now available through an early access program, demonstrated promising efficacy in ...

The most common adverse events in the ketamine groups were headache, cardiorespiratory issues, numbness, tingling, ...

Among 74,000 migraine patients, those taking CGRP inhibitors for migraine prevention had a 25% lower risk of incident ...

Four states have the highest percentage of top-scoring hospitals in the ranking: Connecticut, Virginia, South Carolina, and ...

DENVER -- A sustained-release VEGF inhibitor implant outperformed standard anti-VEGF therapy for maintaining visual acuity in ...